Annual EBITDA:
-$376.16M-$142.66M(-61.10%)Summary
- As of today, RNA annual EBITDA is -$376.16 million, with the most recent change of -$142.66 million (-61.10%) on December 31, 2024.
- During the last 3 years, RNA annual EBITDA has fallen by -$258.75 million (-220.38%).
- RNA annual EBITDA is now -3618.83% below its all-time high of -$10.12 million, reached on December 31, 2018.
Performance
RNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$187.75M-$17.42M(-10.23%)Summary
- As of today, RNA quarterly EBITDA is -$187.75 million, with the most recent change of -$17.42 million (-10.23%) on September 30, 2025.
- Over the past year, RNA quarterly EBITDA has dropped by -$90.33 million (-92.71%).
- RNA quarterly EBITDA is now -9194.55% below its all-time high of -$2.02 million, reached on March 31, 2019.
Performance
RNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$609.06M-$90.33M(-17.41%)Summary
- As of today, RNA TTM EBITDA is -$609.06 million, with the most recent change of -$90.33 million (-17.41%) on September 30, 2025.
- Over the past year, RNA TTM EBITDA has dropped by -$287.02 million (-89.13%).
- RNA TTM EBITDA is now -30051.58% below its all-time high of -$2.02 million, reached on March 31, 2019.
Performance
RNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -61.1% | -92.7% | -89.1% |
| 3Y3 Years | -220.4% | -321.6% | -273.6% |
| 5Y5 Years | -2112.8% | -1552.0% | -2096.7% |
RNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -220.4% | at low | -321.6% | at low | -273.6% | at low |
| 5Y | 5-Year | -2112.8% | at low | -1552.0% | at low | -2096.7% | at low |
| All-Time | All-Time | -3618.8% | at low | -9194.5% | at low | >-9999.0% | at low |
RNA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$187.75M(-10.2%) | -$609.06M(-17.4%) |
| Jun 2025 | - | -$170.33M(-30.3%) | -$518.74M(-20.5%) |
| Mar 2025 | - | -$130.73M(-8.7%) | -$430.35M(-14.4%) |
| Dec 2024 | -$376.16M(-61.1%) | -$120.25M(-23.4%) | -$376.16M(-16.8%) |
| Sep 2024 | - | -$97.42M(-18.9%) | -$322.04M(-14.2%) |
| Jun 2024 | - | -$81.94M(-7.0%) | -$281.94M(-12.2%) |
| Mar 2024 | - | -$76.55M(-15.8%) | -$251.37M(-8.7%) |
| Dec 2023 | -$233.50M(-31.5%) | -$66.13M(-15.4%) | -$231.34M(-6.1%) |
| Sep 2023 | - | -$57.33M(-11.6%) | -$218.06M(-6.2%) |
| Jun 2023 | - | -$51.37M(+9.1%) | -$205.26M(-2.7%) |
| Mar 2023 | - | -$56.52M(-7.0%) | -$199.89M(-12.6%) |
| Dec 2022 | -$177.53M | -$52.84M(-18.7%) | -$177.52M(-8.9%) |
| Sep 2022 | - | -$44.53M(+3.2%) | -$163.01M(-10.5%) |
| Jun 2022 | - | -$46.00M(-34.7%) | -$147.56M(-15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$34.15M(+10.9%) | -$127.78M(-8.9%) |
| Dec 2021 | -$117.41M(-168.2%) | -$38.34M(-31.8%) | -$117.39M(-23.3%) |
| Sep 2021 | - | -$29.08M(-10.9%) | -$95.23M(-22.9%) |
| Jun 2021 | - | -$26.22M(-10.4%) | -$77.51M(-25.7%) |
| Mar 2021 | - | -$23.75M(-46.8%) | -$61.64M(-40.4%) |
| Dec 2020 | -$43.77M(-157.5%) | -$16.18M(-42.3%) | -$43.90M(-58.3%) |
| Sep 2020 | - | -$11.37M(-9.8%) | -$27.73M(-29.1%) |
| Jun 2020 | - | -$10.35M(-72.2%) | -$21.48M(-43.1%) |
| Mar 2020 | - | -$6.01M(-17.3%) | -$15.01M(-36.2%) |
| Dec 2019 | -$17.00M(-68.1%) | - | - |
| Sep 2019 | - | -$5.12M(-32.1%) | -$11.02M(-86.8%) |
| Jun 2019 | - | -$3.88M(-92.0%) | -$5.90M(-192.0%) |
| Mar 2019 | - | -$2.02M | -$2.02M |
| Dec 2018 | -$10.12M | - | - |
FAQ
- What is Avidity Biosciences, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. annual EBITDA year-on-year change?
- What is Avidity Biosciences, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. quarterly EBITDA year-on-year change?
- What is Avidity Biosciences, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. TTM EBITDA year-on-year change?
What is Avidity Biosciences, Inc. annual EBITDA?
The current annual EBITDA of RNA is -$376.16M
What is the all-time high annual EBITDA for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high annual EBITDA is -$10.12M
What is Avidity Biosciences, Inc. annual EBITDA year-on-year change?
Over the past year, RNA annual EBITDA has changed by -$142.66M (-61.10%)
What is Avidity Biosciences, Inc. quarterly EBITDA?
The current quarterly EBITDA of RNA is -$187.75M
What is the all-time high quarterly EBITDA for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high quarterly EBITDA is -$2.02M
What is Avidity Biosciences, Inc. quarterly EBITDA year-on-year change?
Over the past year, RNA quarterly EBITDA has changed by -$90.33M (-92.71%)
What is Avidity Biosciences, Inc. TTM EBITDA?
The current TTM EBITDA of RNA is -$609.06M
What is the all-time high TTM EBITDA for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high TTM EBITDA is -$2.02M
What is Avidity Biosciences, Inc. TTM EBITDA year-on-year change?
Over the past year, RNA TTM EBITDA has changed by -$287.02M (-89.13%)